Orphan Drug Access Threatened By Medicaid Transformation, NORD Says
Executive Summary
National Organization for Rare Disorders raises concerns with proposals to limit US federal financial contributions and coverage requirements in Medicaid programs, maintaining states could limit access to orphan drugs.